Our most recent case study outlines how a certain team at Merck has leveraged OnePager to improve their plan communications.
This is the best way to think of the psychology of how we like to absorb information as humans…well, sort of. Our species has been communicating with drawings for 32,000 years (at least), while reading and writing words are much more recently acquired skills (and still not universal). Why is this important?
One might argue that with the information age, we’re actually taking a turn back toward our ancestral, purely visual selves. After all, what draws your eye in your social feed or in a business meeting? Is it text or images? Right. The more visual the information is, the more quickly we can absorb it and move onto the next thing. We’re moving away from focused study to retrieve information and more toward the laziness (or genius?) of receiving information in blips.
The pharmaceutical industry makes up the one of the largest segments of our OnePager users, and by no coincidence. The visuals that OnePager can create are absolutely ideal for communicating an initiative that has a sequential flow and at any level, however, it is the program and portfolio-level visuals that appear to provide the most obvious value in pharma initially, leading to an eventual and organic shift to a more broad utilization for all plan-related communications. Continue reading